This illustration shows an image of President-elect Donald Trump next to a phone screen that is displaying the Truth Social app, in Washington, D.C., on Feb. 21, 2022.Stefani Reynolds | AFP | Getty ImagesTrump Media and Technology Group is expanding into financial services, including investment vehicles, the firm announced Wednesday.Shares of the Truth Social parent company, which trade under the ticker DJT, jumped more than 10% in premarket trading. President Donald Trump indirectly owns 114,750,000 shares of the company, held in a revocable trust.The financial services division will be known as Truth.Fi, and it will be started with up to…
Author: usaeverydaylife
Here are Wednesday’s biggest calls on Wall Street: Oppenheimer downgrades Apple to perform from outperform Oppenheimer downgraded the stock ahead of earnings Thursday citing a “weaker outlook.” “We see a twofold challenge ahead for iPhone growth: 1) stronger competition in greater China and 2) lack of compelling Apple Intelligence and generative AI apps to accelerate near-term device replacement.” Bernstein initiates Rivian as underperform Bernstein said profitability seems years away for the EV company. “While we see the company succeeding in its plan to reach > 500k units by 2030, this is not enough to create financial success for shareholders. With…
An animated rendering of a Pelican satellite in orbit.PlanetSatellite imagery and data analysis company Planet announced it had signed a $230 million contract on Wednesday, with an anchor customer furthering the rollout of its next-generation Pelican satellites.”It is a momentum-building event. … It’s both our biggest deal ever and it’s a significant step for us into this satellite services business,” Planet CEO Will Marshall told CNBC.Planet’s deal will see it build Pelican satellites in service to a company in the Asia–Pacific region. Planet said the customer will be identified at a later date, but described the company as a long-standing…
PEBBLE BEACH, Calif. — Scottie Scheffler was attempting to make homemade ravioli on Christmas Day — with limited equipment in a rental home — when he realized he’d made a serious mistake. He decided to use an empty wine glass to shape and slice his pasta dough.“I had my hand on top of it and it broke, which, side note, I’ve heard nothing but horror stories since this happened about wine glasses, so be careful,” Scheffler said Tuesday. “Even if you’re like me and you don’t drink wine, you’ve got to be real careful with wine glasses.”The stem of a…
Among the requirements for those seeking permanent residency or citizenship in Britain is a 24-question test designed to assess applicants’ knowledge of their adopted home, covering topics including rugby, the country’s first curry house and the War of the Roses.The test is supposed to prove that applicants have “sufficient knowledge of British values, history and society,” according to the Home Office. But one London woman, the agency said, saw it as a moneymaking opportunity.The woman, 61, was arrested in the British capital on Monday on suspicion of fraudulently completing the exam, known as the “Life in the U.K. Test,” for…
Apple is struggling to keep up with iPhone sales and a competitive artificial intelligence landscape, leading Oppenheimer to move to the sidelines on the stock. The firm downgraded Apple to perform from outperform and removed its $250 price target on the stock, citing a weaker outlook for iPhone sales in the next 12 to 18 months, lack of AI innovation and challenges in the Chinese market. “We see a twofold challenge ahead for iPhone growth: 1) stronger competition in greater China and 2) lack of compelling Apple Intelligence and generative AI apps to accelerate near-term device replacement,” analyst Martin Yang…
Check out the companies making headlines before the bell. F5 – Shares soared nearly 14% on the heels of the application security company’s fiscal second-quarter outlook beating Wall Street’s expectations. F5 expects revenue to come in between $705 million and $725 million, while analysts polled by FactSet had penciled in $702.7 million. Nextracker – The solar tracker manufacturer surged more than 24% after beating revenue expectations and offering stronger-than-expected earnings guidance. Nextracker reported $679.4 million in revenue for the quarter, exceeding the FactSet consensus forecast of $646 million. ASML – U.S.-listed shares of the Dutch semiconductor giant rose 5% after the…
Orbex is a startup that develops both small and medium-sized space rockets. The firm uses a renewable form of propane known as bio-propane to fuel its rockets.Michal Wachucik | AFP via Getty ImagesThe U.K. government announced Wednesday a £20 million ($24.8 million) investment in Orbex, a Scottish spaceflight startup aiming to rival Elon Musk’s SpaceX.The investment — part of a larger funding round that’s being raised by the firm — was revealed at the European Space Conference in Brussels. Orbex raised £23 million for its latest fundraise. Other investors involved include Denmark’s Export & Investment Fund, Octopus Ventures and former Informatica…
The European Central Bank is widely expected to kick off its 2025 meetings with another interest rate cut on Thursday, as traders aim to gauge how far the central bank is willing to diverge from a stalled Federal Reserve.Money markets on Wednesday were pricing in 35 basis points worth of rate cuts for the January meeting, indicating the euro zone’s central bank will cut by at least a quarter-percentage point. That would take the deposit facility, its key rate, to 2.75% marking its fifth trim since it began easing monetary policy in June 2024.Market pricing then suggests follow-up cuts at…
Goldman Sachs has turned more cautious on Moderna as the biotech struggles against strong competition from other vaccine makers. Analyst Salveen Richter downgraded shares from neutral to buy. Additionally, she lowered her price target by $48 from to $51, which suggests about 13.5% potential upside ahead. Richter’s changes are based on revised revenue projections for Moderna’s respiratory syncytial virus, or RSV, and cytomegalovirus, or CMV, vaccines. “We note the recent product revenue guidance represents the second in a series of negative revisions over the last six months, which while potentially at an achievable level, leads us to believe MRNA has…
